iNKT Cell Therapy Delivers Historic Remission in Hard-to-Treat Cancer
A Groundbreaking Cancer Therapy Is Changing Lives For the first time ever, a patient with severe testicular cancer that didn’t respond to treatments has recovered thanks to a trial therapy made from specialized immune cells called iNKT cells. Researchers used a treatment known as agenT-797. MiNK Therapeutics developed this new type of ready-to-use therapy, which […]
iNKT Cell Therapy Delivers Historic Remission in Hard-to-Treat Cancer Read More »